Q96T58 (MINT_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 127.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Msx2-interacting protein Alternative name(s): SMART/HDAC1-associated repressor protein SPEN homolog | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 3664 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May serve as a nuclear matrix platform that organizes and integrates transcriptional responses. In osteoblasts, supports transcription activation: synergizes with RUNX2 to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE) By similarity. Has also been shown to be an essential corepressor protein, which probably regulates different key pathways such as the Notch pathway. Negative regulator of the Notch pathway via its interaction with RBPSUH, which prevents the association between NOTCH1 and RBPSUH, and therefore suppresses the transactivation activity of Notch signaling. Blocks the differentiation of precursor B-cells into marginal zone B-cells. Probably represses transcription via the recruitment of large complexes containing histone deacetylase proteins. May bind both to DNA and RNA. Ref.1 Ref.7 |
| Subunit structure | Interacts with MSX2 and HIPK3 By similarity. Interacts with NCOR2, HDAC1, HDAC2, RBBP4, MBD3 and MTA1L1. Interacts with RBPSUH; this interaction may prevent the interaction between RBPSUH and NOTCH1. Interacts with the nuclear receptors RAR and PPARD. Interacts with RAR in absence of ligand. Binds to the steroid receptor RNA coactivator SRA. Interacts with Epstein-Barr virus BSFL2/BMLF1. Ref.1 Ref.6 Ref.7 Ref.8 |
| Subcellular location | |
| Tissue specificity | Expressed at high level in brain, testis, spleen and thymus. Expressed at intermediate level in kidney, liver, mammary gland and skin. |
| Induction | By 17-beta-estradiol. Ref.1 |
| Domain | The RID domain mediates the interaction with nuclear receptors By similarity. Ref.15 The SPOC domain, which mediates the interaction with NCOR2, is essential for the repressive activity. Ref.15 |
| Sequence similarities | Belongs to the RRM Spen family. Contains 1 RID (receptor interacting) domain. Contains 4 RRM (RNA recognition motif) domains. Contains 1 SPOC domain. |
| Sequence caution | The sequence BAA91405.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence BAB14324.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence CAB51072.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| NCK1 | P16333 | 3 | EBI-765739,EBI-389883 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 3664 | 3664 | Msx2-interacting protein | PRO_0000081627 | |||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||
| Domain | 6 – 81 | 76 | RRM 1 | ||||||||||||||||||||||||||||||||||||||
| Domain | 335 – 415 | 81 | RRM 2 | ||||||||||||||||||||||||||||||||||||||
| Domain | 438 – 513 | 76 | RRM 3 | ||||||||||||||||||||||||||||||||||||||
| Domain | 517 – 589 | 73 | RRM 4 | ||||||||||||||||||||||||||||||||||||||
| Domain | 2201 – 2707 | 507 | RID | ||||||||||||||||||||||||||||||||||||||
| Domain | 3498 – 3664 | 167 | SPOC | ||||||||||||||||||||||||||||||||||||||
| DNA binding | 1 – 573 | 573 | By similarity | ||||||||||||||||||||||||||||||||||||||
| Region | 2130 – 2464 | 335 | Interaction with MSX2 By similarity | ||||||||||||||||||||||||||||||||||||||
| Region | 2709 – 2870 | 162 | Interaction with RBPSUH By similarity | ||||||||||||||||||||||||||||||||||||||
| Coiled coil | 688 – 715 | 28 | Potential | ||||||||||||||||||||||||||||||||||||||
| Coiled coil | 977 – 1004 | 28 | Potential | ||||||||||||||||||||||||||||||||||||||
| Coiled coil | 1170 – 1191 | 22 | Potential | ||||||||||||||||||||||||||||||||||||||
| Coiled coil | 1408 – 1428 | 21 | Potential | ||||||||||||||||||||||||||||||||||||||
| Coiled coil | 1496 – 1529 | 34 | Potential | ||||||||||||||||||||||||||||||||||||||
| Coiled coil | 1592 – 1612 | 21 | Potential | ||||||||||||||||||||||||||||||||||||||
| Coiled coil | 1928 – 1944 | 17 | Potential | ||||||||||||||||||||||||||||||||||||||
| Compositional bias | 125 – 277 | 153 | Arg-rich | ||||||||||||||||||||||||||||||||||||||
| Compositional bias | 240 – 325 | 86 | Ser-rich | ||||||||||||||||||||||||||||||||||||||
| Compositional bias | 616 – 810 | 195 | Arg-rich | ||||||||||||||||||||||||||||||||||||||
| Compositional bias | 624 – 697 | 74 | Tyr-rich | ||||||||||||||||||||||||||||||||||||||
| Compositional bias | 2428 – 2520 | 93 | Pro-rich | ||||||||||||||||||||||||||||||||||||||
| Compositional bias | 3220 – 3482 | 263 | Pro-rich | ||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||
| Modified residue | 309 | 1 | Phosphoserine Ref.13 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 623 | 1 | Phosphoserine Ref.13 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 727 | 1 | Phosphoserine Ref.13 Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 736 | 1 | Phosphoserine Ref.11 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 740 | 1 | Phosphoserine Ref.11 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1062 | 1 | Phosphoserine Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1194 | 1 | Phosphoserine Ref.11 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1222 | 1 | Phosphoserine Ref.12 Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1252 | 1 | Phosphoserine Ref.13 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1261 | 1 | Phosphoserine Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1268 | 1 | Phosphoserine Ref.9 Ref.12 Ref.13 Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1278 | 1 | Phosphoserine Ref.9 Ref.12 Ref.13 Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1283 | 1 | Phosphoserine Ref.9 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1287 | 1 | Phosphoserine Ref.11 Ref.13 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1333 | 1 | Phosphoserine Ref.13 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1380 | 1 | Phosphoserine Ref.9 Ref.11 Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1382 | 1 | Phosphoserine Ref.9 Ref.11 Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1439 | 1 | Phosphothreonine Ref.11 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1441 | 1 | Phosphothreonine Ref.11 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1633 | 1 | Phosphothreonine Ref.13 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1897 | 1 | Phosphoserine Ref.11 Ref.13 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 1947 | 1 | Phosphothreonine Ref.12 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 2101 | 1 | Phosphoserine Ref.13 Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 2120 | 1 | Phosphoserine Ref.11 Ref.13 Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 2126 | 1 | Phosphoserine Ref.11 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 2159 | 1 | Phosphoserine Ref.13 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 2366 | 1 | Phosphoserine Ref.11 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 2421 | 1 | Phosphothreonine Ref.11 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 2452 | 1 | Phosphoserine Ref.12 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 2460 | 1 | Phosphothreonine Ref.12 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 2938 | 1 | Phosphothreonine Ref.11 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 2950 | 1 | Phosphothreonine Ref.11 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 3433 | 1 | Phosphoserine Ref.11 | ||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||
| Natural variant | 970 | 1 | A → V. Corresponds to variant rs848208 [ dbSNP | Ensembl ]. | VAR_017119 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 990 | 1 | D → H in a breast cancer sample; somatic mutation. Ref.16 | VAR_035483 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 1091 | 1 | L → P. Ref.4 Corresponds to variant rs848209 [ dbSNP | Ensembl ]. | VAR_017120 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 1363 | 1 | D → E. Corresponds to variant rs12095818 [ dbSNP | Ensembl ]. | VAR_052208 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 1488 | 1 | R → I in a breast cancer sample; somatic mutation. Ref.16 | VAR_035484 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 2360 | 1 | N → D. Corresponds to variant rs848210 [ dbSNP | Ensembl ]. | VAR_017121 | |||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 956 | 1 | G → D Ref.4 | ||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||
| Helix | 3501 – 3504 | 4 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 3507 – 3515 | 9 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 3518 – 3529 | 12 | |||||||||||||||||||||||||||||||||||||||
| Helix | 3531 – 3537 | 7 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 3547 – 3549 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 3551 – 3554 | 4 | |||||||||||||||||||||||||||||||||||||||
| Helix | 3557 – 3566 | 10 | |||||||||||||||||||||||||||||||||||||||
| Turn | 3570 – 3572 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 3573 – 3580 | 8 | |||||||||||||||||||||||||||||||||||||||
| Helix | 3585 – 3598 | 14 | |||||||||||||||||||||||||||||||||||||||
| Helix | 3600 – 3606 | 7 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 3608 – 3614 | 7 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 3624 – 3629 | 6 | |||||||||||||||||||||||||||||||||||||||
| Helix | 3633 – 3642 | 10 | |||||||||||||||||||||||||||||||||||||||
| Helix | 3644 – 3650 | 7 | |||||||||||||||||||||||||||||||||||||||
| Turn | 3651 – 3653 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 3657 – 3663 | 7 | |||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Sharp, an inducible cofactor that integrates nuclear receptor repression and activation." Shi Y., Downes M., Xie W., Kao H.-Y., Ordentlich P., Tsai C.-C., Hon M., Evans R.M. Genes Dev. 15:1140-1151(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, INDUCTION, RNA-BINDING, INTERACTION WITH NCOR2; HDAC1; HDAC2; RBBP4; MBD3; RAR AND MTA1L1. Tissue: Liver and Pituitary. |
| [2] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | Rhodes S., Huckle E. Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 294-3664. |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 793-1595, VARIANT PRO-1091. Tissue: Embryo and Teratocarcinoma. |
| [5] | "Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O. DNA Res. 6:63-70(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2002-3664. Tissue: Brain. |
| [6] | "The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling." Shi Y., Hon M., Evans R.M. Proc. Natl. Acad. Sci. U.S.A. 99:2613-2618(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PPARD. |
| [7] | "SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway." Oswald F., Kostezka U., Astrahantseff K., Bourteele S., Dillinger K., Zechner U., Ludwig L., Wilda M., Hameister H., Knoechel W., Liptay S., Schmid R.M. EMBO J. 21:5417-5426(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH RBPSUH. |
| [8] | "Interaction of the Epstein-Barr virus mRNA export factor EB2 with human Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links Spen proteins with splicing regulation and mRNA export." Hiriart E., Gruffat H., Buisson M., Mikaelian I., Keppler S., Meresse P., Mercher T., Bernard O.A., Sergeant A., Manet E. J. Biol. Chem. 280:36935-36945(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH EBV BSFL2/BMLF1. |
| [9] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1268; SER-1278; SER-1283; SER-1380 AND SER-1382, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Embryonic kidney. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-736; SER-740; SER-1194; SER-1287; SER-1380; SER-1382; THR-1439; THR-1441; SER-1897; SER-2120; SER-2126; SER-2366; THR-2421; THR-2938; THR-2950 AND SER-3433, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1222; SER-1268; SER-1278; THR-1947; SER-2452 AND THR-2460, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [13] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309; SER-623; SER-727; SER-1252; SER-1268; SER-1278; SER-1287; SER-1333; THR-1633; SER-1897; SER-2101; SER-2120 AND SER-2159, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-727; SER-1062; SER-1222; SER-1261; SER-1268; SER-1278; SER-1380; SER-1382; SER-2101 AND SER-2120, MASS SPECTROMETRY. |
| [15] | "A conserved structural motif reveals the essential transcriptional repression function of Spen proteins and their role in developmental signaling." Ariyoshi M., Schwabe J.W.R. Genes Dev. 17:1909-1920(2003) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF SPOC DOMAIN. |
| [16] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] HIS-990 AND ILE-1488. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF356524 mRNA. Translation: AAK52750.1. AL034555, AL450998 Genomic DNA. Translation: CAI19526.1. AL450998, AL034555 Genomic DNA. Translation: CAH70858.1. AL096858 mRNA. Translation: CAB51072.1. Different initiation. AK000882 mRNA. Translation: BAA91405.1. Different initiation. AK022949 mRNA. Translation: BAB14324.1. Different initiation. AB023146 mRNA. Translation: BAA76773.1. | ||||||||||||
| IPI | IPI00045914. | ||||||||||||
| RefSeq | NP_055816.2. NM_015001.2. | ||||||||||||
| UniGene | Hs.731396. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q96T58. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q96T58. 19 interactions. | ||||||||||||
| STRING | 9606.ENSP00000364912. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q96T58. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 41688816. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q96T58. | ||||||||||||
| PRIDE | Q96T58. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000375759; ENSP00000364912; ENSG00000065526. | ||||||||||||
| GeneID | 23013. | ||||||||||||
| KEGG | hsa:23013. | ||||||||||||
| UCSC | uc001axk.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 23013. | ||||||||||||
| GeneCards | GC01P016174. | ||||||||||||
| H-InvDB | HIX0159662. | ||||||||||||
| HGNC | HGNC:17575. SPEN. | ||||||||||||
| HPA | HPA015825. | ||||||||||||
| MIM | 613484. gene. | ||||||||||||
| neXtProt | NX_Q96T58. | ||||||||||||
| PharmGKB | PA134895302. | ||||||||||||
| HUGE | Search... | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG12793. | ||||||||||||
| HOGENOM | HOG000231295. | ||||||||||||
| HOVERGEN | HBG045583. | ||||||||||||
| InParanoid | Q96T58. | ||||||||||||
| OMA | KHLKPEQ. | ||||||||||||
| OrthoDB | EOG4JM7NS. | ||||||||||||
| PhylomeDB | Q96T58. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q96T58. | ||||||||||||
| Bgee | Q96T58. | ||||||||||||
| CleanEx | HS_SPEN. | ||||||||||||
| Genevestigator | Q96T58. | ||||||||||||
| GermOnline | ENSG00000065526. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 2.40.290.10. 1 hit. 3.30.70.330. 4 hits. | ||||||||||||
| InterPro | IPR012677. Nucleotide-bd_a/b_plait. IPR000504. RRM_dom. IPR012921. SPOC_C. IPR016194. SPOC_like_C_dom. IPR010912. SPOC_met. [Graphical view] | ||||||||||||
| Pfam | PF00076. RRM_1. 3 hits. PF07744. SPOC. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00360. RRM. 4 hits. [Graphical view] | ||||||||||||
| SUPFAM | SSF100939. SPOC-like. 1 hit. | ||||||||||||
| PROSITE | PS50102. RRM. 4 hits. PS50917. SPOC. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChiTaRS | SPEN. human. | ||||||||||||
| EvolutionaryTrace | Q96T58. | ||||||||||||
| GenomeRNAi | 23013. | ||||||||||||
| NextBio | 43936. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | MINT_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q96T58 Secondary accession number(s): Q9H9A8 Q9Y556 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
